A new multitargeted drug candidate in Alzheimer disease: 1,4-dihydropyridine-benzylidenhydrazon derived AChE inhibitor


SEVİN G. , Alançay E., Yılmaz S., ALPTÜZÜN V. , YETİK ANACAK G.

Second WG Meeting COST ACTION CA15135, Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig), 15 - 16 Mart 2018